Avitaminosis (Hypovitaminosis) - Pipeline Review, H2 2012

Publisher Name :
Date: 31-Oct-2012
No. of pages: 36
Inquire Before Buying

Avitaminosis (Hypovitaminosis) - Pipeline Review, H2 2012

Summary

Global Markets Direct's, 'Avitaminosis (Hypovitaminosis) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Avitaminosis (Hypovitaminosis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Avitaminosis (Hypovitaminosis). Avitaminosis (Hypovitaminosis) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Avitaminosis (Hypovitaminosis).
- A review of the Avitaminosis (Hypovitaminosis) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Avitaminosis (Hypovitaminosis) pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Avitaminosis (Hypovitaminosis).
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Avitaminosis (Hypovitaminosis) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Avitaminosis (Hypovitaminosis) - Pipeline Review, H2 2012

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Avitaminosis (Hypovitaminosis) Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Avitaminosis (Hypovitaminosis) 7
Avitaminosis (Hypovitaminosis) Therapeutics under Development by Companies 9
Avitaminosis (Hypovitaminosis) Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Avitaminosis (Hypovitaminosis) Therapeutics - Products under Development by Companies 14
Avitaminosis (Hypovitaminosis) Therapeutics - Products under Investigation by Universities/Institutes 15
Companies Involved in Avitaminosis (Hypovitaminosis) Therapeutics Development 16
Kyowa Hakko Kirin Co., Ltd. 16
Zeria Pharmaceutical Co Ltd 17
Emisphere Technologies, Inc. 18
Cytochroma Inc. 19
Avitaminosis (Hypovitaminosis) - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
sodium phosphate - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
CTAP-101 - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
KRN-23 - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
cholecalciferol - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Avitaminosis (Hypovitaminosis) Therapeutics - Drug Profile Updates 29
Avitaminosis (Hypovitaminosis) Therapeutics - Dormant Products 32
Avitaminosis (Hypovitaminosis) - Product Development Milestones 33
Featured News & Press Releases 33
Sep 20, 2012: Cytochroma Initiates Phase III Study Of CTAP101 Capsules In Chronic Kidney Disease Patients 33
Nov 02, 2009: Interim Study Data Demonstrate Eligen B12 Oral Formulation Achieves Comparable Results to B12 Injection 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 36
Disclaimer 36

List of Tables
Number of Products Under Development for Avitaminosis (Hypovitaminosis), H2 2012 7
Products under Development for Avitaminosis (Hypovitaminosis) - Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Number of Products under Investigation by Universities/Institutes, H2 2012 10
Comparative Analysis by Late Stage Development, H2 2012 11
Comparative Analysis by Mid Clinical Stage Development, H2 2012 12
Comparative Analysis by Early Clinical Stage Development, H2 2012 13
Products under Development by Companies, H2 2012 14
Products under Investigation by Universities/Institutes, H2 2012 15
Kyowa Hakko Kirin Co., Ltd., H2 2012 16
Zeria Pharmaceutical Co Ltd, H2 2012 17
Emisphere Technologies, Inc., H2 2012 18
Cytochroma Inc., H2 2012 19
Assessment by Monotherapy Products, H2 2012 20
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Stage and Molecule Type, H2 2012 24
Avitaminosis (Hypovitaminosis) Therapeutics - Drug Profile Updates 29
Avitaminosis (Hypovitaminosis) Therapeutics - Dormant Products 32

List of Figures
Number of Products under Development for Avitaminosis (Hypovitaminosis), H2 2012 7
Products under Development for Avitaminosis (Hypovitaminosis) - Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Products under Investigation by Universities/Institutes, H2 2012 10
Late Stage Products, H2 2012 11
Mid Clinical Stage Products, H2 2012 12
Early Clinical Stage Products, H2 2012 13
Assessment by Monotherapy Products, H2 2012 20
Assessment by Route of Administration, H2 2012 21
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Molecule Type, H2 2012 23
Assessment by Stage and Molecule Type, H2 2012 24

  • Global Metabolic Partnering 2010-2016: Deal trends, players and financials
    Published: 01-May-2016        Price: US 2995 Onwards        Pages: 500
    "Delivery of this report will take 1-3 days after purchase." Global Metabolic Partnering 2010 to 2016 provides the full collection of Metabolic disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Metabolic partnering deals Financial deal terms for headline, upfront and royalty by stage of development Metabolic partnering agreement structure Metabolic partnering contract documents Top M......
  • Global Lysosomal Storage Disease Partnering 2010-2016
    Published: 01-Apr-2016        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. Trends in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding ......
  • Fabry Disease-Pipeline Insights, 2016
    Published: 01-Jan-2016        Price: US 1250 Onwards        Pages: 60
    SUMMARY DelveInsight's, " Fabry Disease-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fabry Disease. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations,......
  • Lysosomal Storage Disorder-Pipeline Insights, 2016
    Published: 01-Jan-2016        Price: US 1250 Onwards        Pages: 60
    SUMMARY DelveInsight's, " Lysosomal Storage Disorder-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Lysosomal Storage Disorder. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, ......
  • Metabolic Syndrome-Pipeline Insights, 2016
    Published: 01-Jan-2016        Price: US 1250 Onwards        Pages: 60
    SUMMARY DelveInsight's, " Metabolic Syndrome-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Metabolic Syndrome. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, colla......
  • Mucopolysaccharidosis-Pipeline Insights, 2016
    Published: 01-Jan-2016        Price: US 1250 Onwards        Pages: 60
    SUMMARY DelveInsight's, " Mucopolysaccharidosis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Mucopolysaccharidosis. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing,......
  • Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )-Pipeline Insights, 2016
    Published: 01-Jan-2016        Price: US 1250 Onwards        Pages: 60
    SUMMARY DelveInsight's, " Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ). The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and oth......
  • Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )-Pipeline Insights, 2016
    Published: 01-Jan-2016        Price: US 1250 Onwards        Pages: 60
    SUMMARY DelveInsight's, " Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ). The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and......
  • Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )-Pipeline Insights, 2016
    Published: 01-Jan-2016        Price: US 1250 Onwards        Pages: 60
    SUMMARY DelveInsight's, " Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ). The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials inf......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs